Share this article
Share this article
Watchmaker Genomics and Molecular Loop Announce Partnership to Expand Access to High-Performance Genetic Tests for SARS-CoV-2 Surveillance
BOULDER, Colo., May 4, 2021 /PRNewswire/ --
Watchmaker Genomics, a life science tools company that specializes in high-performance genomics application development, and
Molecular Loop, an industry-leader in molecular inversion probe (MIP)-based assays, have announced a collaboration to accelerate the commercialization of streamlined, high-stringency genetic testing for pathogen surveillance.
Watchmaker brings deep domain expertise in computational biology, high-throughput enzyme engineering, and large-scale enzyme production to further enable Molecular Loop's advanced assay technologies. MIPs leverages highly redundant probe tiling and a streamlined workflow to eliminate the need for traditional shotgun library preparation, combining the sensitivity and specificity of hybridization-based target enrichment with the ease and scalability of amplicon-based assays. The partnership between the two companies makes it possible to deliver powerful new assays that address unmet needs related to throughput, performance, scalability, and consistency of supply.